Bookmarks
Eye images and retinopathy grades in diabetic eye screening
Population Size
Years
2020 - 2021
Associated BioSamples
None/not available
Geographic coverage
United Kingdom
England
Lead time
2-6 months
Summary
Documentation
Background Diabetes mellitus affects over 3.9 million people in the United Kingdom (UK), with over 2.6 million people in England alone. Diabetic retinopathy (DR) is a common microvascular complication of type 1 and type 2 diabetes and remains a major cause of vision loss and blindness in those of working age. The National Institute for Health and Care Excellence recommendations are for annual screening using digital retinal photography for all patients with diabetes aged 12 years and over until such time as specialist surveillance or referral to Hospital Eye Services (HES) is required.
Birmingham, Solihull and Black Country DR screening program is a member of the National Health Service (NHS) Diabetic Eye Screening Programme. This dataset contains routine community annual longitudinal screening patient results of over 200000 patients with screening results per patient ranging from 1 year to 15 years. Key data included in this imaging dataset are: • Fundal photographs • The national screening diabetic grade category (seven categories from R0M0 to R3M1) • Screening Outcome (digital surveillance and time; referral to HES)
Geography Birmingham, Solihull and Black Country is set within the West Midlands and has a population of circa 5.9million. The region includes a diverse ethnic, and socio-economic mix, with a higher than UK average of minority ethnic groups. It has a large number of elderly residents but is the youngest population in the UK. There are particularly high rates of diabetes, physical inactivity, obesity, and smoking.
Data source: The Birmingham, Solihull and Black Country Data Set, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. They manage over 200,000 patients, with longitudinal follow-up up to 15 years, making this the largest urban diabetic screening scheme in Europe.
Dataset type
Dataset sub-type
Associated media
Keywords
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
---|---|---|---|---|
Events | Over 200,000 patients 2.5 million grading events at any level 1.68 million gradings including ophthalmology referrals 1 million final grades from community screens 0ver 6 million images over 15 years | 200000 | Count | 01 Oct 2021 |
Provenance
Purpose of dataset collection
Source of data extraction
Collection source setting
Patient pathway description
Image contrast
Biological sample availability
Structural Metadata
Details
Publishing frequency
Version
Modified
08/10/2024
Distribution release date
01/10/2021
Citation Requirements
Coverage
Start date
30/11/2020
End date
31/03/2021
Time lag
Geographic coverage
Minimum age range
Maximum age range
Follow-up
10 Years
Accessibility
Language
Controlled vocabulary
Format
Data Access Request
Dataset pipeline status
Access rights
Time to dataset access
Access request cost
Access method category
Access service description
Jurisdiction
Data use limitation
Data use requirements
Data Controller